Page 11 - Analyst Note News Today

stocks as economic growth rebounds, JPMorgan said in a note on Wednesday. Easy monetary and fiscal policy, a weak US dollar, and stronger inflation will spark heightened demand for commodities in the years ahead, the note said. Investors are under allocated to the energy sector based off of its current weighting in the S&P 500, JPMorgan highlighted. . A supercycle in commodities is about to take place and investors can benefit by increasing their exposure to energy stocks, JPMorgan said in a ...

The January jobs report missed estimates on Friday, but its significance is limited and wont ultimately hinder the stock markets upward path, according to

The stock market has 20% upside potential from current levels, according to a Thursday note from JPMorgan. Analysts at the bank said the bull market in stocks

A sharp decline in COVID-19 cases is leading to a newfound risk-on mode for the stock market, Fundstrats Tom Lee said in a note on Thursday. The bullish groundswell

Investors should stay pro-risk and continue buying stocks as a synchronized global expansion takes hold thanks to mass vaccinations, JPMorgans Marko Kolanovic

» Wildly overvalued: A former Wall Street chief strategist says its time for stock bulls to sell their holdings - and warns of a particularly vicious comeuppance for small-caps Wildly overvalued: A former Wall Street chief strategist says its time for stock bulls to sell their holdings - and warns of a particularly vicious comeuppance for small-caps Matthew FoxJan 10, 2021, 20:23 IST Traders and financial professionals work ahead of the closing bell on the floor of the New York Stock Exchange ...

Learn about DVN (XNYS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on DVN.

Feb 4, 2021 No-moat Change Healthcare released third-quarter results after the close Feb. 3 that were largely in line with expectations. Overall revenue was slightly short of consensus estimates as tracked by FactSet. The slight top-line shortfall was somewhat offset by lower-than-expected operating expenses, likely a result of the rightsizing ahead of the pending acquisition. Last month, UnitedHealth Group’s services arm, Optum, announced plans to acquire Change Healthcare for $25...

Feb 11, 2021 Kinross reported fourth-quarter results with few surprises, as its production of 2.4 million gold equivalent ounces at cost of sales of $723 per ounce and all-in sustaining cost of $987 per ounce were within guidance. With average realized gold prices 30% higher than last year, adjusted operating cash flow rose 36% to $528 million. Read Full Analysis Business Description Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million...

Feb 3, 2021 No-moat FireEye topped FactSet consensus estimates with 5% year-over-year revenue growth and an adjusted EPS of $0.12 in the fourth quarter. With its leading capabilities in security response and threat intelligence, we expect FireEye to be a main benefactor of the Sunburst breach. Revenue recognized in the quarter that was related to the widespread breach was minimal due to timing but solidly increased deferred revenue for services. Our expectation is that FireEye servic...